Form 4: Abbott Laboratories Director Reports Stock Transaction
Insider Transaction (Form 4)
Kevin T Conroy, a Director of Abbott Laboratories, reported a transaction in 52,507 shares of common stock on September 23, 2026.
Summary
- Tax/exercise-price withholding: disposed of 52,507 Common shares without par value at $103.99 ($5,460,203) on September 23, 2026; holds 81,230 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kevin T Conroy — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-23 | Tax/exercise-price withholding | Common shares without par value | 52,507 | $104 | $5.5M | 81,230 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-23 | Tax/exercise-price withholding (52,507 shares) |
Keywords
insider transaction, Form 4, ABT, ABBOTT LABORATORIES, neutral, Kevin T Conroy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.